Pre-earnings options volume in Bionano Genomics is normal with calls leading puts 8:5. Implied volatility suggests the market is anticipating a move near 13.9%, or 19c, after results are released. Median move over the past eight quarters is 6.7%.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly
See today’s best-performing stocks on TipRanks >>
Read More on BNGO:
- Bionano Genomics obtains class I registrations from China’s NMPA
- Bionano Announces China NMPA Approval for DNA Extraction and Labeling Products for IVD Use in Hematologic Malignancies
- Bionano Shares Overview of AGBT Pre-Conference Workshop Program Along with Details of Company’s Innovative Research Grant Opportunity
- Bionano Stock: Big Ideas, Big Potential
- Bionano Genomics Symposium 2023 featured ‘record numbers’ of presentations